By Canadian Press

Shares in cannabis company Tilray up following U.K. supply deal with Grow Pharma

Feb 9, 2021 | 8:59 AM

NANAIMO, B.C. — Shares in cannabis company Tilray Inc. soared after the announcement of a deal with Grow Pharma to supply medical cannabis in the United Kingdom.

Tilray shares were up US$11.43 at US$41.52 in late-morning trading on the Nasdaq market.

Grow Pharma is a leading medical cannabis distributor in the United Kingdom.

Tilray, based in Nanaimo, B.C., says it expects to have a range of medical cannabis products available for patients in the United Kingdom by March.

Tilray announced a deal last year to merge with Leamington, Ont.-based Aphria Inc. 

conduct standards

Provincewide code of conduct coming for B.C.'s elected officials

13h ago

Batter Up

Mid Island Pirates full of optimism as baseball season begins

16h ago

headed to trial

Wife of Nanaimo prosecutor pleads not guilty to fraud & theft charges

Apr 02, 2026

The cannabis companies have said the move will help them slash costs and give them control of the biggest slice of the Canadian retail market.

This report by The Canadian Press was first published Feb. 9, 2021.

The Canadian Press